Flanders Institute for Biotechnology (Vib)

VIB’s Jérôme van Biervliet says on The BioCentury Show that Europe needs to fulfill its long overdue mission in biotech as the U.S. enters uncertain terrain

Plus: Novo Holdings, Jeito lead week’s largest A round for VIB company Augustine — and more

The growing power of tools for holistically studying human biology should free researchers from narrow searches in discovery

Across disciplines, researchers are navigating trade-offs in advancing translation that boil down to scope versus focus 

Only nine other biotechs have raised over $25 million since 2015

Plus: Airna, ReviR, LTZ and Synthetica draw Series A cash, while Outpace, Confo and Healx refill their coffers

Researchers link Nav1.7 to osteoarthritis progression and identify a modulator of Nav1.6 for epilepsy

Private European company gets $40M up front for AGTR2-targeting small molecule in Phase I; deal also includes preclinical antibody